TY - JOUR
KW - Dose-Response Relationship, Drug
KW - Drug Administration Schedule
KW - Female
KW - Follow-Up Studies
KW - Humans
KW - leprosy
KW - Long-Term Care
KW - Male
KW - Peripheral Nervous System Diseases
KW - Prednisolone
KW - Randomized Controlled Trials as Topic
KW - Recovery of Function
KW - Risk Assessment
KW - Sensation Disorders
KW - Severity of Illness Index
KW - Time Factors
KW - Treatment Outcome
AU - Naafs B
AB - <p>In this paper, earlier data on the length of prednisolone treatment are re-examined. Based on those data and supported by the literature and the author's own observations, it can be concluded that type I leprosy reaction should be treated with prednisolone for a longer period than the 12 weeks, advised by the WHO. The paper also warns against silent nerve damage that may occur when prednisolone is discontinued early.</p>
BT - Leprosy review
C1 - http://www.ncbi.nlm.nih.gov/pubmed/14750578?dopt=Abstract
CN - NAAFS 2003
DA - 2003 Dec
IS - 4
J2 - Lepr Rev
LA - eng
N2 - <p>In this paper, earlier data on the length of prednisolone treatment are re-examined. Based on those data and supported by the literature and the author's own observations, it can be concluded that type I leprosy reaction should be treated with prednisolone for a longer period than the 12 weeks, advised by the WHO. The paper also warns against silent nerve damage that may occur when prednisolone is discontinued early.</p>
PY - 2003
SP - 328
EP - 36
T2 - Leprosy review
TI - Treatment duration of reversal reaction: a reappraisal. Back to the past.
UR - https://leprosyreview.org/article/74/4/32-8336
VL - 74
SN - 0305-7518
ER -